852287-65-1

Upstream product

• 853569-67-2 2-(4-methoxy-2-methylphenyl)-3-oxobutyronitrile potassium salt 
• 563-41-7 semicarbazide hydrochloride 

Relevant academic research and scientific papers

Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist

The present invention provides 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-α]-pyrazolo-1,3,5-triazine benzenesulfonate salt and a crystalline polymorph thereof. Further provided are pharmaceutical compositions containing th

PROCESSES FOR THE PREPARATION OF PYRAZOLO[1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF

The present invention provides novel processes and intermediates for preparing corticotropin releasing factor (CRF) receptor antagonists having the structure below which are useful in treating CRF-related disorders such as anxiety and depression.